Dr. Kasim A. Mookhtiar is the co-founder, Chief Executive of Advinus Therapeutics Ltd, India’s first innovative pharmaceutical research and development company, which is funded and supported by the Tata group of companies. Prior to co-founding Advinus, he was Vice President, New Drug Discovery Research, at Ranbaxy Laboratories Limited, where he led a team of over 200 scientists from multiple disciplines.
After completing a 5-year integrated MS in Chemistry at the Indian Institute of Technology, Bombay, where he worked in Synthetic Organic Chemistry, Kasim pursued a PhD with Professor H. E. Van Wart at the Institute of Molecular Biophysics, Florida State University, Tallahassee, Florida, USA. His graduate work encompassed biochemistry, protein chemistry, enzyme kinetics and inhibition. Kasim followed up his graduate work with a postdoctoral stint at Yale University School of Medicine, where he learned molecular biology and structural biology (2D NMR).
He joined the Metabolic Diseases Drug Discovery group at the Bristol-Myers Squibb Pharmaceutical Research Institute in Princeton, NJ, USA, where he worked from1992 to 2003. Early in his career he pioneered of the Diabetes and Obesity programs at BMS and was then entrusted with the task of forming the Department of Aging Research in Drug Discovery, a very novel and cutting edge area for both basic and applied research. He was responsible for the strategic planning of this area and was also involved in numerous strategic efforts in the wider BMS activities.
Rajiv Malik is the Chief Operating Officer of Advinus Therapeutics. He was a founding employee of the Company and served as its Chief of Business Operations from inception to June 2012, during which time he played a pivotal role in setting up the company and driving its business and strategy. After a short stint away, Rajiv returned to Advinus to work with the CEO in driving the overall business and strategic efforts of the Company. He is also responsible for the Company’s contract research business as it’s Business Unit Head.
Rajiv has held several senior and leadership positions with leading companies in India and has diverse working experience in the Pharmaceutical, Biotech, Contract Research and IT sectors. He has over 25 years of experience in managing business operations particularly in startup and turnaround environments. Just prior to rejoining Advinus, Rajiv served as Executive Vice President at Intas Pharmaceuticals Limited, where he was responsible for the International Business of Intas, for all markets other than US and Europe. He also lead the biosmilars and other biologics business of Intas as well as its corporate business development and licensing portfolio.
Rajiv holds a Master’s degree in Business Administration (MBA) from the US and a Bachelor’s degree in Economics.
Mr. S D Gopalakrishnan is a B.Com Graduate from the Madras University and is also an Associate Member of the Institute of Cost Accountants of India. He has nearly four decades of rich and extensive experience in Financial and Management Accounting, Commercial Operations, Indirect Taxation and Costing. With in-depth knowledge in various disciplines of accounting and finance and proficiency in developing and implementing systems for streamlining various controls and processes, S D Gopalakrishnan joins Advinus with proven abilities to contribute towards improvement in operations, business growth and profit through analytical MIS and effective internal controls. Prior to joining Advinus, he was with Titan Company Limited, another Tata Group company, as an Associate Vice President, Commercial, and was instrumental in implementing the costing system for the watch, jewelry and precision engineering divisions of the company, establishing robust processes for business planning, monitoring performance and hedging the foreign currency exposures. He also played a key role in the implementation of SAP and Oracle systems in the company and in the setup of the Joint Venture of the company with Timex Watches Limited. At Titan, he was also a member of Watch Business Council of the Watch and Accessories Division of the Company apart from being a member of the Titan Management Council.
Dr. Vikram K. Ramanathan is Senior Vice President and Head of Technical Operations at Advinus Bangalore. A founding employee of Advinus from 2005, he played a pivotal role in setting up its DMPK department and served the Company for about eight years. In addition to his role as Head of DMPK and Clinical Pharmacology, he also led the preclinical and clinical development of Advinus’ internal molecules. After a short stint away, he rejoined the Company in 2015.
Vikram obtained his PhD from the Pharmaceutical Chemistry graduate program (Pharmaceutics pathway), School of Pharmacy at the University of California at San Francisco under the guidance of Dr. Kathleen M. Giacomini in whose laboratory he studied epithelial neurotransmitter transporters and their role in pharmacokinetics and disposition. He subsequently did a postdoctoral fellowship in Dr. Zach W. Hall’s laboratory at the NIH, Bethesda, where he used cellular and molecular techniques to study the cellular trafficking and expression of the muscarinic acetylcholine receptor.
Vikram has over 18 years of pharma industry experience in drug discovery and development, in both R&D and CRO settings, in the US and India. He started his career at SmithKline Beecham/GlaxoSmithKline in the Philadelphia area where he spent several years before returning to India to set up and head the Discovery DMPK department at Ranbaxy Research Laboratories in Gurgaon. Prior to rejoining Advinus, he was Vice President, DMPK and Bioanalysis at Cadila Healthcare Ltd. where he supported the development of NCEs, biologicals and generic drugs.